Building a National Capability to Monitor and Assess Medical Countermeasure Use During a Public Health Emergency - Going Beyond the Last Mile: Proceedings of a Workshop

During public health emergencies (PHEs) involving chemical, biological, radiological, or nuclear threats or emerging infectious diseases, medical countermeasures (MCMs) (e.g., drugs, vaccines, devices) may need to be dispensed or administered to affected populations to help mitigate the human health impact of the threat.